Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you stopped Wegovy about two months ago and you're wondering what restarting looks like, the short answer is this: after a gap of eight weeks, your prescriber will almost certainly recommend going back to a lower dose rather than picking up where you left off. That's not a setback — it's how semaglutide works safely. These are prescription-only medicines, and a prescriber needs to review your situation before treatment resumes.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture the last eight weeks. Your final dose of semaglutide has a half-life of roughly a week, so by the time a month had passed, the medicine was essentially gone from your system. By now (two months in) your GLP-1 receptors are no longer being stimulated, gastric emptying has returned to its pre-treatment rate, and the appetite suppression that made smaller portions feel natural has faded.
For many people this shows up on the scales. Research into semaglutide consistently finds that weight tends to return after stopping, at a pace that varies person to person but often starts within weeks. The NHS medicines page for semaglutide notes that weight management medicines work alongside lifestyle changes rather than instead of them, which is partly why a break can undo progress faster than expected. None of this means restarting is futile, it means doing it properly matters.
The practical thing to do right now, before anything else, is to weigh yourself and note the figure. One minute, one number. You'll need it for your prescriber, and seeing it written down is more useful than estimating from how your clothes feel.
This is the question most people ask first. You finished on, say, 1.7mg or 2.4mg. Going back to that dose immediately sounds logical, you tolerated it before. But clinical guidance is clear: after a significant gap, the body's tolerance to GI side effects essentially resets.
Restarting at a higher dose than your system is currently accustomed to raises the chance of the nausea, vomiting, and cramping that were most noticeable in the early weeks of your first course. Starting lower is not a clinical downgrade; it's how the medicine is used safely after a break. Your prescriber decides exactly where to restart based on how long you were off and how you're doing now. The dose schedule for Wegovy is described in full in the Wegovy Summary of Product Characteristics on the eMC, the definitive reference for prescribers making that call.
If you were on Wegovy through a different provider, you'll need evidence of your previous treatment before a prescriber at a new pharmacy can review a dose increase. Transfer patients are asked to provide that documentation as part of a standard clinical re-assessment.
GI symptoms tend to be most prominent in the first few weeks of a new or restarted course. Nausea is the most commonly reported; loose stools, indigestion, and fatigue are also frequent. Most people find these settle over a couple of weeks as the body re-adjusts. Taking semaglutide alongside a light, low-fat meal can help, though your prescriber or the Patient Information Leaflet should be your guide on managing them day to day.
There are situations where you should seek medical help promptly rather than waiting to see if things settle. Severe stomach pain that spreads toward your back (particularly if it is persistent or comes with vomiting) warrants urgent assessment; this is a symptom pattern associated with pancreatitis, which the MHRA highlighted in a 2026 Drug Safety Update on GLP-1 medicines. Signs of a serious allergic reaction (swelling of the face, lips or throat, difficulty breathing) also need emergency care. You can report any suspected side effect through the MHRA Yellow Card scheme.
For a broader look at how semaglutide works and what the full side-effect profile looks like, that page covers the mechanism in more detail. If your gap has been shorter, the guidance on restarting Wegovy after one month explains what a briefer pause typically means for your restart dose, and people who stopped around the six-week mark may find the advice on restarting Wegovy after four months a useful comparison point. And if your gap has stretched closer to three months, the considerations around restarting Wegovy after three months are worth reading too, as are the notes on restarting Wegovy after six months if you think your break may run longer than expected.
Wegovy is a prescription-only medicine. Restarting legally means a prescriber reviewing your case, your current weight, any health changes since you stopped, what dose is appropriate to restart on, and whether semaglutide is still the right choice for you. Some people who have been off treatment for several months find that switching to a different option makes more clinical sense; that's a conversation for the consultation, not something to decide alone.
At nume, every consultation is read by a GPhC-registered Independent Prescriber on the same day you submit it, a named clinician, not a queue for automated triage. If approved as clinically suitable, orders placed before noon on weekdays are dispatched the same day and delivered free the next working day in plain, unbranded packaging. If you'd like to understand more about what Wegovy costs privately in the UK, that page sets out the honest picture, including what legitimate providers include in the price.
People who stopped for other reasons (an operation, a pregnancy scare, a period of illness) sometimes find they stopped at a lower dose and are unsure whether to retrace the full titration. Others stopped because of side effects and are wondering whether a slower restart might help. Our frequently asked questions cover a range of these scenarios, and our clinical team is there to discuss the specifics once you've started a consultation. To explore your options and check whether Wegovy or another licensed treatment is appropriate for you, speak to our prescribers, the consultation is free.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.